Kenjiro Okada1, Yoshiaki Murakami2, Naru Kondo2, Kenichiro Uemura2, Naoya Nakagawa2, Shingo Seo2, Shinya Takahashi2, Taijiro Sueda2. 1. Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. kenokada@hiroshima-u.ac.jp. 2. Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Abstract
BACKGROUNDS AND OBJECTIVES: Although metastasis in lymph nodes along the left side of superior mesenteric artery (SMA-LNs-lt) is sometimes found, survival benefit of SMA-LN-lt dissection for pancreatic head cancer is still unclear. The purpose of this study is to evaluate the prognostic significance of SMA-LN-lt metastasis and micrometastasis. METHODS: A total of 166 patients with pancreatic head cancer who underwent pancreatectomy with lymphadenectomy including SMA-LNs-lt between 2002 and 2017 were reviewed retrospectively. Micrometastasis was evaluated by immunohistochemistry. RESULTS: Twenty patients (12%) had SMA-LN-lt metastasis detected by hematoxylin and eosin (HE) staining, and eight patients (5%) had micrometastasis. Patients with SMA-LN-lt HE-positive or micrometastasis group experienced significantly shorter overall survival (OS) than those without (p = .015). In multivariate analysis, SMA-LN-lt HE-positive or micrometastasis (p = .034), portal vein resection (p = .002), histologic grade 2/3 (p = .046), LN metastasis (p = .002), and lack of adjuvant chemotherapy (p < .001) were independent risk factors. Within a subset of SMA-LN-lt HE-positive or micrometastasis group, lack of adjuvant chemotherapy (p = .003) was the independent poor prognostic factor. CONCLUSIONS: In pancreatic head cancer, the rate of SMA-LN-lt HE-positive and micrometastasis was found in 12% and 5%, respectively. Adjuvant chemotherapy may contribute to improvement of prognosis in patients with LN metastasis including SMA-LN-lt metastasis and micrometastasis.
BACKGROUNDS AND OBJECTIVES: Although metastasis in lymph nodes along the left side of superior mesenteric artery (SMA-LNs-lt) is sometimes found, survival benefit of SMA-LN-lt dissection for pancreatic head cancer is still unclear. The purpose of this study is to evaluate the prognostic significance of SMA-LN-lt metastasis and micrometastasis. METHODS: A total of 166 patients with pancreatic head cancer who underwent pancreatectomy with lymphadenectomy including SMA-LNs-lt between 2002 and 2017 were reviewed retrospectively. Micrometastasis was evaluated by immunohistochemistry. RESULTS: Twenty patients (12%) had SMA-LN-lt metastasis detected by hematoxylin and eosin (HE) staining, and eight patients (5%) had micrometastasis. Patients with SMA-LN-lt HE-positive or micrometastasis group experienced significantly shorter overall survival (OS) than those without (p = .015). In multivariate analysis, SMA-LN-lt HE-positive or micrometastasis (p = .034), portal vein resection (p = .002), histologic grade 2/3 (p = .046), LN metastasis (p = .002), and lack of adjuvant chemotherapy (p < .001) were independent risk factors. Within a subset of SMA-LN-lt HE-positive or micrometastasis group, lack of adjuvant chemotherapy (p = .003) was the independent poor prognostic factor. CONCLUSIONS: In pancreatic head cancer, the rate of SMA-LN-lt HE-positive and micrometastasis was found in 12% and 5%, respectively. Adjuvant chemotherapy may contribute to improvement of prognosis in patients with LN metastasis including SMA-LN-lt metastasis and micrometastasis.
Entities:
Keywords:
Adjuvant chemotherapy; Lymph node metastasis; Micrometastasis; Pancreatic head cancer; Superior mesenteric artery
Authors: L Schwarz; R M Lupinacci; M Svrcek; M Lesurtel; M Bubenheim; H Vuarnesson; P Balladur; F Paye Journal: Br J Surg Date: 2014-04 Impact factor: 6.939
Authors: Nigel B Jamieson; Alan K Foulis; Karin A Oien; James J Going; Paul Glen; Euan J Dickson; Clem W Imrie; Colin J McKay; Ross Carter Journal: Ann Surg Date: 2010-06 Impact factor: 12.969
Authors: Giuseppe Malleo; Laura Maggino; Paola Capelli; Francesco Gulino; Silvia Segattini; Aldo Scarpa; Claudio Bassi; Giovanni Butturini; Roberto Salvia Journal: J Am Coll Surg Date: 2015-02-28 Impact factor: 6.113
Authors: Johanna A M G Tol; Dirk J Gouma; Claudio Bassi; Christos Dervenis; Marco Montorsi; Mustapha Adham; Ake Andrén-Sandberg; Horacio J Asbun; Maximilian Bockhorn; Markus W Büchler; Kevin C Conlon; Laureano Fernández-Cruz; Abe Fingerhut; Helmut Friess; Werner Hartwig; Jakob R Izbicki; Keith D Lillemoe; Miroslav N Milicevic; John P Neoptolemos; Shailesh V Shrikhande; Charles M Vollmer; Charles J Yeo; Richard M Charnley Journal: Surgery Date: 2014-07-22 Impact factor: 3.982
Authors: Takuji Okusaka; H Miyakawa; H Fujii; S Nakamori; T Satoh; Y Hamamoto; T Ito; H Maguchi; S Matsumoto; H Ueno; T Ioka; N Boku; S Egawa; T Hatori; J Furuse; K Mizumoto; S Ohkawa; T Yamaguchi; K Yamao; A Funakoshi; J S Chen; A L Cheng; A Sato; Y Ohashi; M Tanaka Journal: J Cancer Res Clin Oncol Date: 2017-02-16 Impact factor: 4.553